Back to Journals » Drug Design, Development and Therapy » Volume 8

Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway

Total article views   HTML views PDF downloads Totals
15,670 Dovepress* 14,734+ 1,661 16,395
PubMed Central* 936 406 1,342
Totals 15,670 2,067 17,737
*Since 12 December 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 0 3

View citations on PubMed Central and Google Scholar